The World Health Organization has advised doctors against prescribing Gilead’s remdesivir to coronavirus patients in hospital, casting doubt on the effectiveness of the only antiviral approved to treat the disease.
Remdesivir was approved by the US Food and Drug Administration (FDA) last month.
But an expert WHO panel wrote in the British Medical Journal on Friday that the drug was “not suggested for patients admitted to hospital with Covid-19, regardless of how severely ill they are, because there is currently no evidence that it improves survival or the need for ventilation”.
您已阅读15%（582字），剩余85%（3391字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。